iCellate is a Swedish research and development company focused on cancer research and detection products.
iCellate has raised $1.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
iCellate's investors include Sting.
iCellate is headquartered in Stockholm, Sweden.
iCellate is a Swedish research and development company focused on cancer research and detection products.
iCellate is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iCellate — Funding & Investors." VCBacked, May 19, 2023, https://www.vcbacked.co/company/icellate. Accessed August 14, 2026.
VCBacked. (2023). iCellate — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/icellate
{{cite web |title=iCellate — Funding & Investors |url=https://www.vcbacked.co/company/icellate |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated